From “Shelfware” to Strategic Asset: Reviving a Failed Pharma LIMS
The “#BurnVictim” Scenario
A global pharmaceutical lab was struggling with a Tier-1 LIMS that had become “shelfware.” After 18 months, user adoption was stuck at 15%. The team was suffering from “scar tissue”—a deep hesitation to innovate because the current digital environment felt more burdensome than the manual processes it replaced.
The Recovery Framework
To rescue this project, we applied the LIMS Implementation & Readiness Audit—a 5-phase methodology designed to identify structural and human bottlenecks before they stall a project.
Learn more about the 5-Phase Audit used in this project →Solving the “Search Tax”
Using our Phase 2: Data Architecture pillars, we integrated HPLC and GC instruments directly. By eliminating manual transcription from these “Islands of Data,” we provided the lab with 100% audit integrity and immediate “Time-Back.”
Scientist-First UX
Following our Phase 4: The Human Factor guidelines, we pruned 40% of non-essential fields. We focused on the “bench scientist” experience, ensuring the system worked for the researcher rather than acting as a reporting tool for management.